Clinical Trials on Metastatic Liver Carcinoma in Russian Federation

Total 846 results

Alpha Tau Medical LTD.

Terminated

Alpha Radiation Emitters Device for the Treatment of Newly Diagnosed Breast Carcinoma Patients With Distant Metastases

Metastatic Breast Cancer | Breast Carcinoma | Invasive Breast Cancer | Distant Metastases.Pathology

Russian Federation
Central Clinical Hospital RZD-Medicine, Russian...

Recruiting

Prevention and Treatment of Complications of Endovascular Methods in Patients With Malignant Liver Tumors (PATOC)

Metastatic Cancer | Chemotherapy Effect | Hepatic Cancer

Russian Federation
Kidney Cancer Research Bureau

Completed

Study of Capecitabine in Metastatic Non-clear Cell Renal Cell Carcinoma (RCC) Patients

Metastatic Renal Cell Carcinoma

Russian Federation
Saint Petersburg State University, Russia

Withdrawn

Pembrolizumab and Lenvatinib/Chemotherapy for Poorly Differentiated/Anaplastic Thyroid Cancer

Poorly Differentiated Thyroid Gland Carcinoma | Metastatic Thyroid Gland Carcinoma | Thyroid Gland Anaplastic Carcinoma by AJCC V8 Stage

Russian Federation
Kidney Cancer Research Bureau

Unknown

Intrapleural Instillation of the Nivolumab in Cancer Patients With Pleural Effusion.

Non-small Cell Lung Cancer Metastatic | Pleural Effusion, Malignant | Renal Cell Cancer Metastatic

Russian Federation
Kidney Cancer Research Bureau

Completed

Safety and Preliminary Efficacy of SBRT in Patients With Metastatic RCC Treated With Targeted or IO Therapy

Metastatic Renal Cell Carcinoma

Russian Federation
Federal State Budgetary Scientific Institution...

Completed

Comparative Efficacy of Liver Fibrosis and Steatosis Assessment With Fibroscan and iLivTouch (OGIG-01-22-LF)

Liver Fibrosis | Chronic Liver Disease | Liver Steatoses

Russian Federation
Blokhin's Russian Cancer Research Center
Russian Society of Clinical Oncology

Completed

Abemaciclib for the Treatment of Luminal Metastatic breAst caNcer in the Real-life Clinical pracTice in Russia. (ATLANT)

Metastatic Disease | HR+/HER2- Breast Cancer | Аdvanced Disease

Russian Federation
Eli Lilly and Company

Completed

Pemetrexed and Carboplatin in Locally Advanced or Metastatic Breast Cancer

Breast Cancer | Neoplasm Metastasis

Russian Federation
Kidney Cancer Research Bureau

Completed

Testosterone in Metastatic Renal Cell Carcinoma Patients (FARETES)

Metastatic Renal Cell Carcinoma

Russian Federation
Kidney Cancer Research Bureau

Completed

Everolimus in Patients With Metastatic Renal Cell Carcinoma Following Progression on Prior Bevacizumab Treatment

Metastatic Renal Cell Carcinoma

Russian Federation
Russian Academy of Medical Sciences
Federal State Budgetary Scientific Institution "Federal Research Centre of...

Unknown

Safety and Tolerability of Novel Medical Nutrition Products for NAFLD Treatment (052920190055)

NAFLD | NASH - Nonalcoholic Steatohepatitis

Russian Federation
Puma Biotechnology, Inc.

Completed

Study Evaluating The PK And Safety Of Neratinib In Healthy Subjects And Subjects With Chronic Liver Disease

Hepatic Insufficiency

Russian Federation
I.M. Sechenov First Moscow State Medical University

Completed

Probiotics and Hemodynamic Changes in Cirrhosis (PrBHCCir)

Cirrhosis

Russian Federation
Sanofi

Completed

Essentiale® Paste in Patients With Gastrointestinal Symptoms in Acute or Chronic Liver Diseases (EPLID)

Hepatic and Hepatobiliary Disorders

Russian Federation
I.M. Sechenov First Moscow State Medical University

Completed

Evaluation of the Effect of IHHT on Vascular Stiffness and Elasticity of the Liver Tissue in Patients With MS.

Metabolic Syndrome | Vascular Stiffness | Liver Fibroses | Trimethylamine N-oxyde | Toll-like Receptors

Russian Federation
Movetis

Completed

Evaluation of Prucalopride in Subjects With Moderate and Severe Hepatic Impairment (HI)

Hepatic Impairment

Russian Federation
POLYSAN Scientific & Technological Pharmaceutical...

Terminated

Runihol in Nonalcoholic Fatty Liver Disease and Metabolic Syndrome

Non-alcoholic Fatty Liver Disease

Russian Federation
National Medical Research Center for Therapy and...
Center for Strategic Planning and Management of Biomedical Health Risks of...

Completed

Gut Microbiota in Chronic Noncommunicable Diseases

Diabetes Mellitus, Type 2 | Asthma | Nonalcoholic Fatty Liver Disease | Arterial Hypertension | Heart Failure With Reduced Ejection Fraction | Heart Failure With Preserved Ejection Fraction | Obstructive Pulmonary Disease | Atherosclerosis Occlusive Disease

Russian Federation
AstraZeneca

Active, not recruiting

A Study to Investigate Efficacy and Safety of Ceralasertib Plus Durvalumab in Participants Aged ≥ 18 Years With Advanced or Metastatic Non-small Cell Lung Cancer Whose Disease Progressed on or After Prior Anti-PD-(L)1 Therapy and Platinum-based Chemotherapy (LOTOS)

Advanced or Metastatic NSCLC

Russian Federation
Mona Frolova

Unknown

Neoadjuvant Chemotherapy Followed by Preoperative Chemoradiation in Resectable Squamous-cell Esophageal Cancer

Esophageal Neoplasms | Squamous Cell Carcinoma | Concurrent Chemoradiotherapy

Russian Federation
Novartis Pharmaceuticals

Completed

Pharmacokinetics of Everolimus in Subjects With Hepatic Insufficiency

Hepatic Insufficiency

Germany, Russian Federation, Singapore
I.M. Sechenov First Moscow State Medical University

Recruiting

The Evaluation of Functional Parenchymal Volume and Split Renal Function Before and After Partial Nephrectomy

Renal Cell Carcinoma

Russian Federation
Kidney Cancer Research Bureau

Unknown

Nivolumab and Ipilimumab in T1aN0M0 Renal Cell Carcinoma Patients Ineligible for Surgical Treatment.

Renal Cell Carcinoma

Russian Federation
Kidney Cancer Research Bureau

Completed

Granulocyte-macrophage Colony-stimulating Factor, Interferon and Interleukin-2 as Adjuvant Treatment for Renal Cancer

Renal Cell Carcinoma

Russian Federation
Kidney Cancer Research Bureau

Completed

Capecitabine and Interferon-Alpha in Metastatic Renal Cell Carcinoma Patients With Failure on Interleukin-2 Based Regimens

Carcinoma, Renal Cell

Russian Federation
Kidney Cancer Research Bureau

Completed

Palliative Radiofrequency Ablation in Metastatic Renal Cell Carcinoma Patients

Carcinoma, Renal Cell

Russian Federation
Blokhin's Russian Cancer Research Center

Recruiting

FOLFOX6 Versus mFOLFIRINOX as First Line Chemotherapy in Metastatic Gastric Cancer or Esophagogastric Junction Adenocarcinoma (Type II-III) (IRIGA)

Gastric Carcinoma Stage IV | Esophagogastric Junction Adenocarcinoma Stage IV

Russian Federation
Viriom

Completed

Study to Evaluate the Safety and PK of Elpida® in Healthy Subjects and Patients With Hepatic Impairment and to Assess the Impact of Food Intake and Drug-Drug Interactions With Other Antiviral Drugs

Hepatic Impairment | HIV-1-infection

Russian Federation
Russian Academy of Medical Sciences

Completed

Autologous Dendritic Cell Vaccine for Treatment of Patients With Chronic HCV-Infection

Liver Diseases | Virus Diseases | Hepatitis | Hepatitis C, Chronic

Russian Federation
Moscow Clinical Scientific Center

Completed

Comparison of Hydro-dissection Versus Ultrasonic Aspirator in Division of Liver Parenchyma in Laparoscopic Resection (LLS)

Liver Transection During Laparoscopic Liver Resection

Russian Federation
Blokhin's Russian Cancer Research Center

Recruiting

The Efficacy of Neoadjuvant Chemoradiotherapy in Comparison With Neoadjuvant Chemotherapy in Patients With Resectable Squamous Cell Esophageal Cancer

Esophageal Cancer

Russian Federation
Biocad

Terminated

Non-comparative Study of BCD-085 in Combination With UDCA in Patients With Primary Biliary Cholangitis

Liver Cirrhosis, Biliary

Russian Federation
Novartis Pharmaceuticals

Completed

Pharmacokinetics of RLX030 in Subjects With Mild, Moderate and Severe Hepatic Impairment Compared to Healthy Subjects

Hepatic Impairment

Germany, Russian Federation
R-Pharm
Ascent

Completed

A Pharmacokinetic Study of Narlaprevir as a Single Dose or With Ritonavir Combination in Patients With Hepatic Impairment and Healthy Matched Volunteers

Hepatic Impairment

Georgia, Russian Federation
Saint Petersburg State University, Russia

Withdrawn

Dabrafenib and Trametinib Combination as a Neoadjuvant Strategy in BRAF-positive Anaplastic Thyroid Cancer (ANAPLAST-NEO)

Thyroid Gland Anaplastic Carcinoma

Russian Federation
Abbott
Ascent; Datamap; ClinIntel; Catalent

Completed

Study With Heptral in Subjects With Liver Disease Due to Alcohol Consumption

Intrahepatic Cholestasis Associated With Alcoholic Liver Disease

Russian Federation
National Medical Research Center for Therapy and...

Recruiting

Efficacy and Safety of Pitavastatin and PCSK9 Inhibitors in Liver Transplant Patients (PINTL)

Dyslipidemias | Hyperlipidemias | Liver Transplant Disorder | Immunosuppression | Hydroxymethylglutaryl-CoA Reductase Inhibitors | Statins

Russian Federation
Bayer

Completed

Sorafenib as Neoadjuvant Therapy Before Cytoreductive Nephrectomy in Patients With Metastatic Renal Cell Carcinoma (SANE)

Carcinoma, Renal Cell

Russian Federation
N.N. Petrov National Medical Research Center of...

Recruiting

Stereotactic Radiation Therapy for HE2-positive Oligometastatic Breast Cancer

Oligometastatic Disease | HER2-positive Metastatic Breast Cancer

Russian Federation
Biocad

Unknown

A Study of BCD-135 in Patients With Advanced Solid Tumors

Melanoma | Renal Cell Carcinoma | NSCLC | Bladder Cancer

Russian Federation
Meshalkin Research Institute of Pathology of Circulation

Completed

Effects of Anesthesia on Immunity in Cancer

Surgery | Renal Cancer

Russian Federation
Novartis Pharmaceuticals

Completed

Pharmacokinetics of BAF312 in Patients With Hepatic Impairment

Hepatic Impairment

Hungary, Russian Federation
Avionco LLC

Completed

Safety, Tolerability and Pharmacokinetics of ONC1-0013B in Patients With Progressive Metastatic Castration-resistant Prostate Cancer

Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Russian Federation
POLYSAN Scientific & Technological Pharmaceutical...

Recruiting

Remaxol® in Patients With Drug-induced Liver Injuries During Cancer Chemotherapy

Cancer | Drug Induced Liver Injury

Russian Federation
Autonomous Non-Profit Organization National Society...

Recruiting

Treatment of Patients With Stage III Non-small Cell Lung Cancer in Russia"

Stage III Non-small Cell Lung Cancer

Russian Federation
Achieve Life Sciences

Completed

Safety and Efficacy of S-8184 in Second Line Treatment of Relapsed Stage IIIB or IV Non Small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

Russian Federation
N.N. Blokhin National Medical Research Center of...

Recruiting

Osimertinib for Russian EGFR T790M Mutation-positive NSCLC Patients Who Progressed on or After EGFR TKI Therapy (TRUST)

Non Small Cell Lung Cancer | EGFR Gene Mutation | T790M

Russian Federation
MelanomaPRO, Russia
Privolzhsky Research Medical University

Recruiting

Clinical vAlidation of a MobilE appLication ("ProRodinki") in the Assessment of the maLignant skIn neoplAsms (CAMELLIA)

Nevus | Nevus, Pigmented | Melanoma (Skin) | Basal Cell Carcinoma | Squamous Cell Carcinoma | Bowen's Disease | Nevus, Spitz | Melanoma in Situ | Nevus Halo | Spot Pigmented

Russian Federation
Russian Academy of Medical Sciences

Unknown

Paclitaxel and Cisplatin as First-Line Treatment for Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial Cancer

Ovarian Cancer

Russian Federation

Clinical Trials on Metastatic Liver Carcinoma in Russian Federation

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Guinea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations